Bago Group
Laboratorios Bagó is an Argentine pharmaceutical company founded in 1934 that develops and manufactures prescription drugs, OTC consumer health products (Bagóvit, Bagó+), and is expanding into medical technology. It serves physicians, pharmacists, patients, and healthcare institutions primarily in Argentina with exports to multiple countries.
- Company typePrivate
- Founded1934
- HeadquartersBuenos Aires, Argentina
- Headcount5,001–10,000
- GTM typeB2B and B2C
- OfferingHardware or Manufacturing
What Bago Group does
Laboratorios Bagó S.A. is an Argentine pharmaceutical company founded in 1934, headquartered in Buenos Aires, with manufacturing operations in La Plata. The company develops, manufactures, and distributes prescription pharmaceutical products, over-the-counter (OTC) consumer health products, the Bagóvit skincare line, and the Bagó+ vitamin supplement line. Its R&D operation is anchored by 148 granted patents (including 56 original molecule discoveries and 92 manufacturing procedure patents) and more than 100 active R&D projects that use AI, pharmacometric tools, and in vitro and in silico methodologies. In December 2025 the company inaugurated an ANMAT-approved Bioanalytical Center at its La Plata plant, joining a select group of six such authorized centers in Argentina for bioequivalence studies.
The company's revenue model combines prescription pharmaceutical sales (promoted through a medical representative sales force targeting physicians and pharmacists), OTC and consumer health distribution through pharmacy retail, and international export to multiple countries including markets in Asia. Customer segments span healthcare professionals (physicians, pharmacists), end consumers of OTC and supplement products, and healthcare institutions engaging in pharmacovigilance and institutional programs. The company maintains three operating sub-brands — Bagóvit (skincare), Bagó+ (vitamins), and Bagó Innova (digital medical education platform for healthcare professionals) — and has extended into medical technology through a 2021 partnership with FIUNER to develop a long-term Holter cardiac monitoring device. Bagó is the #1-ranked pharmaceutical company in Argentina by corporate reputation (MERCO), #14th among the country's 100 most prestigious companies, and operates with 5,001-10,000 employees.
Bago Group firmographics
Firmographics- Name
- Bago Group
- Legal name
- Laboratorios Bagó S.A.
- Website
- https://bago.com.ar
- Company type
- Private
- Founded year
- 1934
- Operating status
- Operating
- Headcount range
- 5,001–10,000 employees
- Short description
- Laboratorios Bagó is an Argentine pharmaceutical company founded in 1934 that develops and manufactures prescription drugs, OTC consumer health products (Bagóvit, Bagó+), and is expanding into medical technology. It serves physicians, pharmacists, patients, and healthcare institutions primarily in Argentina with exports to multiple countries.
- Ownership category
- akta.pro rank
Bago Group industry classification
Industry- Product category
- Pharmaceutical Manufacturing
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Medicinal and Botanical Manufacturing (325411)
- SIC
- Medicinal Chemicals & Botanical Products (2833)
- akta.pro primary industry
- Contract Development & Manufacturing for Generics (CDMO/CMO) (HLAIABAI)
- akta.pro secondary industries
- OTC Medicines & Consumer Health Products Distribution (CRAOAHAB), Dermatology OTC & Skin Health (Acne Treatments, Eczema/Psoriasis OTC, Antifungals, Wart Removal) (CRADAMAF)
Keywords
Where Bago Group is headquartered
LocationHeadquarters
- HQ city
- Buenos Aires
- HQ country
- Argentina
- HQ region
- Latin America
Offices2 records
Markets served
Bago Group business model
Business model- GTM type
- B2B and B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Supply Chain, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Revenue model
- Prescription Pharmaceutical Products: Research-based pharmaceutical products sold through medical prescriptions, representing the core business of Laboratorios Bagó. Products span multiple therapeutic areas including cardiovascular, neurological, and general healthcare.
- Over-the-Counter (OTC) Products: Consumer health products including Bagóvit skincare line and Bagó+ vitamin supplements sold directly through pharmacies and retail channels.
- Bagóvit Skincare: Dermatological and cosmetic products including Bagóvit Efecto Luminoso cream and other skincare formulations sold through pharmacies.
- Bagó+ Vitamin Supplements: Vitamin supplement line launched in 2021 for maintaining wellbeing and health balance across different life stages.
Go-to-market motion2 records
Distribution channels3 records
Marketing channels5 records
Bago Group product offering
Product offeringCore offering
Laboratorios Bagó researches, develops, manufactures, and commercializes pharmaceutical products spanning prescription medications and over-the-counter consumer health items across multiple therapeutic areas including cardiovascular, neurological, and dermatological. The company also markets proprietary OTC brands such as Bagóvit skincare and Bagó+ vitamin supplements through Argentine pharmacies, and exports its products internationally. It supports its portfolio with a 148-patent R&D engine, an ANMAT-approved Bioanalytical Center for bioequivalence studies, and the Bagó Innova digital platform serving healthcare professionals.
Differentiator
Problem solved
Functional benefit
Brands
- Bagóvit: Over-the-counter skincare product line including creams like Bagóvit Efecto Luminoso (Light Effect) with mineral pigments, carotenoids, and vitamin A for skin illumination and hydration.
- Bagó+
- Bagó Innova
Products and services
- Prescription Pharmaceutical Products Prescription-only pharmaceutical products distributed through medical representatives and pharmacy networks, spanning cardiovascular, neurological, and general healthcare therapeutic areas for physicians and patients.
- Over-the-Counter (OTC) Pharmaceutical Products Non-prescription pharmaceutical and consumer health products sold directly to consumers through Argentine pharmacy chains and independent pharmacies.
- Bagó+ Vitamin Supplements Line of vitamin supplements designed for maintaining well-being and health balance across different life stages, sold through Argentine pharmacies with Laboratorios Bagó's scientific backing.
- Bagóvit Skincare Line Dermatological and cosmetic products including the Bagóvit Efecto Luminoso cream, featuring ultra-light, hypoallergenic, paraben-free formula with illuminating mineral pigments, carotenoids, vitamin A, and maca/ginger extract, sold through Argentine pharmacies.
Quantifiable outcome
- 6th ANMAT-authorized bioanalytical center in Argentina
- +2 more outcomes
Companies that use Bago Group
Customer profileSegments3 records
Ideal customer profiles3 records
Bago Group technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability1 record
Feature3 records
Bago Group partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- FIUNER (Facultad de Ingeniería, Universidad Nacional de Entre Ríos)corePartnership with FIUNER to design and prototype a long-term Electrocardiographic Signal Recording System (Holter) with 15-30 day duration capability. The agreement represents Laboratorios Bagó's first medical technology development project as part of its new Health Application Technologies division. Electronic and firmware development conducted at FIUNER's Prototyping Laboratory.
- INTA (Instituto Nacional de Tecnología Agropecuaria)corePartnership with INTA (Argentine Agency in Agriculture and Livestock Technology) for joint COVID-19 research. INTA contributed expertise in agricultural and livestock nanotechnology and biotechnology research while Laboratorios Bagó contributed its commitment to innovation to tackle the pandemic through vaccine development research.
Scale indicators7 records
Recent moves6 records
Expansion highlights5 records
Bago Group competitors and assessment
Company assessmentDirect peers
- Elea Pharmaceuticals: Argentine pharmaceutical company focused on branded generics and women's health, with regional export presence; competes with Bagó in pharmacy distribution and several shared therapeutic categories.
- Laboratorios Roemmers: Argentina's largest domestically owned pharmaceutical company, founded in 1921, with a comparable portfolio of branded prescription and OTC products, domestic manufacturing, and regional export presence — the closest direct competitor to Bagó in the Argentine pharma market.
- Laboratorios Gador: Argentine pharmaceutical manufacturer with a strong branded generics and innovative drug portfolio, also exporting across Latin America; competes head-to-head with Bagó in cardiology, neurology, and central nervous system therapeutic areas.
- Laboratorios Richmond: Argentine pharmaceutical company with a focus on branded generics, biotechnology (notably viral vector and mRNA platforms), and contract manufacturing — overlapping with Bagó on prescription pharma and now expanding into biologics where Bagó also has R&D ambitions.
- Biol (Laboratorios BIOL): Argentine generics manufacturer with strong ANMAT regulatory standing and export activity, including biosimilars; competes with Bagó's generics and bioequivalence pipeline for the same physician and pharmacy channels.
- Laboratorios Montpellier: Mid-sized Argentine pharmaceutical company with a portfolio in neurology, psychiatry, and OTC consumer health — a regional peer overlapping Bagó's therapeutic areas and consumer brands such as Bagóvit.
Broad incumbents
- Eurofarma Laboratórios: Brazilian multinational pharmaceutical company with broad prescription, OTC, generics, and CDMO operations across Latin America — competes with Bagó in export markets and offers similar vertically integrated manufacturing scale.
- Genomma Lab Internacional: Latin American OTC and personal care leader with a portfolio of consumer health brands sold across the region — the primary competitive benchmark for Bagó's Bagóvit skincare and Bagó+ vitamin sub-brands.
- Bayer (Consumer Health / Pharma): Global pharmaceutical and consumer health major with a deep presence in Argentina across Rx, OTC, vitamins and dermatology — overlaps Bagó across virtually every category but at materially greater scale and marketing investment.
Others
- Procavi (Grupo Bagó subsidiary): Group-level consumer brand referenced under "Pacientes" on Bagó's site; relevant as a sibling channel for consumer health distribution rather than a direct competitor.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks3 records
Key highlights7 records
Customer concentration
Bago Group social profiles
Digital presenceBago Group compliance and trust
Trust signalCompliance3 records
Bago Group financial estimates
Financial estimateRevenue estimate
Valuation estimate
Bago Group leadership team
Management profileNumber of profiles
Profiles2 records
Bago Group funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Bago Group M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Bago Group
What does Bago Group do?
Laboratorios Bagó researches, develops, manufactures, and commercializes pharmaceutical products spanning prescription medications and over-the-counter consumer health items across multiple therapeutic areas including cardiovascular, neurological, and dermatological. The company also markets proprietary OTC brands such as Bagóvit skincare and Bagó+ vitamin supplements through Argentine pharmacies, and exports its products internationally. It supports its portfolio with a 148-patent R&D engine, an ANMAT-approved Bioanalytical Center for bioequivalence studies, and the Bagó Innova digital platform serving healthcare professionals.
Is Bago Group a public or private company?
Bago Group is a private company. It is classified as family owned and is currently operating.
When was Bago Group founded?
Bago Group was founded in 1934. It employs 5,001 to 10,000 people.
Where is Bago Group based?
Bago Group is headquartered in Buenos Aires, Argentina, in the Latin America region.
How does Bago Group make money?
Four revenue lines are on record. Prescription Pharmaceutical Products are the primary driver. The others are over-the-Counter (OTC) Products, bagóvit Skincare and bagó+ Vitamin Supplements.
Who are Bago Group's main competitors?
Direct peers on record are Elea Pharmaceuticals, Laboratorios Roemmers, Laboratorios Gador, Laboratorios Richmond, Biol (Laboratorios BIOL) and Laboratorios Montpellier. Broad incumbents are Eurofarma Laboratórios, Genomma Lab Internacional and Bayer (Consumer Health / Pharma). Procavi (Grupo Bagó subsidiary) is listed as an others.
Does Bago Group have an API?
No public API is recorded for Bago Group.
What industry is Bago Group in?
Bago Group's product category is Pharmaceutical Manufacturing. Its primary akta.pro industry code is HLAIABAI, Contract Development & Manufacturing for Generics (CDMO/CMO), with a secondary code of CRAOAHAB, OTC Medicines & Consumer Health Products Distribution. Its NAICS code is 325412 and its SIC code is 2833.